Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies
暂无分享,去创建一个
Mehran Kardar | Herman N. Eisen | Arup K. Chakraborty | Dennis R. Burton | Jordi Mata-Fink | K. Dane Wittrup | D. Irvine | A. Chakraborty | M. Kardar | D. Burton | K. Wittrup | Shenshen Wang | H. Eisen | M. Hanson | Darrell J. Irvine | Shenshen Wang | Barry Kriegsman | Melissa Hanson | J. Mata-Fink | B. Kriegsman
[1] C. Berek,et al. Maturation of the immune response in germinal centers , 1991, Cell.
[2] R C Stevens,et al. Structural insights into the evolution of an antibody combining site. , 1997, Science.
[3] C. Milstein,et al. Mutation Drift and Repertoire Shift in the Maturation of the Immune Response , 1987, Immunological reviews.
[4] M. Neuberger,et al. Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. , 1998, Immunity.
[5] Dagmar Iber,et al. An analysis of B cell selection mechanisms in germinal centers. , 2006, Mathematical medicine and biology : a journal of the IMA.
[6] Peter D. Kwong,et al. The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.
[7] C. Kocks,et al. Stepwise intraclonal maturation of antibody affinity through somatic hypermutation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Shlomchik,et al. Clone: a Monte-Carlo computer simulation of B cell clonal expansion, somatic mutation, and antigen-driven selection. , 1998, Current topics in microbiology and immunology.
[9] T. Leanderson,et al. Somatic Mutation of Immunoglobulin V Genes in Vitro , 1996, Science.
[10] D. Baker,et al. Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant , 2011, PloS one.
[11] Peter D. Kwong,et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites , 2002, Nature.
[12] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[13] M. Shlomchik,et al. Germinal centers , 2012, Immunological reviews.
[14] Michael W Deem,et al. Sequence space localization in the immune system response to vaccination and disease. , 2003, Physical review letters.
[15] C. Milstein,et al. Codon bias targets mutation , 1995, Nature.
[16] Michael Meyer-Hermann,et al. Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter , 2010, Cell.
[17] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[18] P Nieuwenhuis,et al. Functional anatomy of germinal centers. , 1984, The American journal of anatomy.
[19] Wayne M Patrick,et al. User-friendly algorithms for estimating completeness and diversity in randomized protein-encoding libraries. , 2003, Protein engineering.
[20] John P. Moore,et al. Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer , 2013, Science.
[21] Feng Gao,et al. Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies , 2014, Cell.
[22] John P. Moore,et al. Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer , 2013, Science.
[23] Young Do Kwon,et al. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility , 2009, Proceedings of the National Academy of Sciences.
[24] J. Mascola,et al. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning , 2013, Nature Reviews Immunology.
[25] Can Keşmir,et al. A spatial model of germinal center reactions: cellular adhesion based sorting of B cells results in efficient affinity maturation. , 2003, Journal of theoretical biology.
[26] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[27] G. Kelsoe,et al. The germinal center: a crucible for lymphocyte selection. , 1996, Seminars in immunology.
[28] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[29] N. Haigwood,et al. Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies , 2011, Journal of Virology.
[30] D. Calado,et al. Germinal Centers , 2017, Methods in Molecular Biology.
[31] Tongqing Zhou,et al. Structure and immune recognition of trimeric prefusion HIV-1 Env , 2014, Nature.
[32] K Dane Wittrup,et al. Isolating and engineering human antibodies using yeast surface display , 2006, Nature Protocols.
[33] H. Eisen,et al. VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE. , 1964, Biochemistry.
[34] Eugene I. Shakhnovich,et al. Optimality of Mutation and Selection in Germinal Centers , 2010, PLoS Comput. Biol..
[35] Dennis R. Burton,et al. Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design , 2003, Journal of Virology.
[36] Tongqing Zhou,et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.
[37] Thomas B. Kepler,et al. Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation , 2014, Front. Immunol..
[38] Adam Godzik,et al. A Blueprint for HIV Vaccine Discovery. , 2012, Cell host & microbe.
[39] P. Sharp,et al. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation , 1992, Journal of virology.
[40] Holly Janes,et al. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.
[41] D R Burton,et al. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[42] Florian Klein,et al. Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy , 2014, Cell.
[43] S. Targ,et al. T Follicular Helper Cell Dynamics in Germinal Centers , 2013, Science.
[44] D. Roopenian,et al. Efficient Mucosal Delivery of Vaccine Using the FcRn-Mediated IgG Transfer Pathway , 2011, Nature Biotechnology.
[45] Pham Phung,et al. Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.
[46] Michael Meyer-Hermann,et al. A mathematical model for the germinal center morphology and affinity maturation. , 2002, Journal of theoretical biology.
[47] W. Paul,et al. The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody. , 1968, Journal of immunology.
[48] David Harel,et al. The Lymph Node B Cell Immune Response: Dynamic Analysis In-Silico , 2008, Proceedings of the IEEE.
[49] F. Sallusto,et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. , 2013, Immunity.
[50] Jason G. Cyster,et al. Imaging of Germinal Center Selection Events During Affinity Maturation , 2007, Science.
[51] G. Kelsoe,et al. In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations , 1991, The Journal of experimental medicine.
[52] J. Sodroski,et al. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein , 1992, Journal of virology.
[53] B. Haynes,et al. HIV‐1 neutralizing antibodies: understanding nature's pathways , 2013, Immunological reviews.
[54] Chaim A. Schramm,et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus , 2013, Nature.
[55] T. Kepler,et al. Somatic hypermutation in B cells: an optimal control treatment. , 1993, Journal of theoretical biology.
[56] Tongqing Zhou,et al. Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 , 2009, Science.
[57] N. Haigwood,et al. Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially. , 2012, Vaccine.
[58] L. Stamatatos,et al. Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope. , 2010, Structure.
[59] R. Doms,et al. Comparing Antigenicity and Immunogenicity of Engineered gp120 , 2005, Journal of Virology.
[60] D. Irvine,et al. Rapid conformational epitope mapping of anti-gp120 antibodies with a designed mutant panel displayed on yeast. , 2012, Journal of molecular biology.
[61] A S Perelson,et al. Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts. , 1997, Journal of immunology.
[62] D R Burton,et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. , 1994, Science.
[63] Tongqing Zhou,et al. Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization , 2013, Cell.
[64] Andrew E. Firth,et al. Statistics of protein library construction , 2005, Bioinform..
[65] F. Kroese,et al. Germinal centers develop oligoclonally , 1987, European journal of immunology.